BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 15809526)

  • 1. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
    Filippatos GS; Anker SD; Kremastinos DT
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle wasting in cardiac cachexia.
    Strassburg S; Springer J; Anker SD
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The syndrome of cardiac cachexia.
    Anker SD; Sharma R
    Int J Cardiol; 2002 Sep; 85(1):51-66. PubMed ID: 12163209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac cachexia.
    Anker SD; Steinborn W; Strassburg S
    Ann Med; 2004; 36(7):518-29. PubMed ID: 15513302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle wasting in heart failure: An overview.
    von Haehling S; Steinbeck L; Doehner W; Springer J; Anker SD
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2257-65. PubMed ID: 23665153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.
    Ebner N; Elsner S; Springer J; von Haehling S
    Curr Opin Support Palliat Care; 2014 Mar; 8(1):15-24. PubMed ID: 24452279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of skeletal muscle atrophy.
    Ventadour S; Attaix D
    Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II as candidate of cardiac cachexia.
    Delafontaine P; Akao M
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):220-4. PubMed ID: 16607120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting.
    Dave S; Patel BM
    Fundam Clin Pharmacol; 2023 Dec; 37(6):1079-1091. PubMed ID: 37474262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
    Anker SD; Coats AJ
    Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.
    Bowen TS; Adams V; Werner S; Fischer T; Vinke P; Brogger MN; Mangner N; Linke A; Sehr P; Lewis J; Labeit D; Gasch A; Labeit S
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):939-953. PubMed ID: 28887874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 and muscle wasting in chronic heart failure.
    Schulze PC; Späte U
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2023-35. PubMed ID: 15964237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.
    Heineke J; Auger-Messier M; Xu J; Sargent M; York A; Welle S; Molkentin JD
    Circulation; 2010 Jan; 121(3):419-25. PubMed ID: 20065166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac cachexia: the mandate to increase clinician awareness.
    Lena A; Ebner N; Coats AJS; Anker MS
    Curr Opin Support Palliat Care; 2019 Dec; 13(4):298-304. PubMed ID: 31469664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic exercise training as therapy for cardiac and cancer cachexia.
    Alves CR; da Cunha TF; da Paixão NA; Brum PC
    Life Sci; 2015 Mar; 125():9-14. PubMed ID: 25500304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
    Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of biological sex in cardiac cachexia.
    Holder ER; Alibhai FJ; Caudle SL; McDermott JC; Tobin SW
    Am J Physiol Heart Circ Physiol; 2022 Oct; 323(4):H609-H627. PubMed ID: 35960634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.